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Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon
but there are increasing reports of the emergence of resistance during DAP therapy.
Most clinical DAP-resistant S. aureus isolates investigated carried mutations in the
mprF gene. The aim of this study was to identify mutations between a clinical pair of
methicillin-susceptible S. aureus (MSSA) isolates (DAP-susceptible and DAP-resistant).
Additionally, the activity of genes previously associated with DAP resistance was
assessed.
Materials and Methods: Two MSSA isolates from patient with left-sided endocarditis
were analyzed by whole genome sequencing (WGS) and reverse transcription-
quantitative real-time PCR (RT-qPCR). The first isolate, DAP-susceptible, was obtained
before initiation of treatment and the second isolate, DAP-resistant, was recovered after
4 weeks of DAP therapy.
Results: Comparison of complete genomes of DAP-susceptible and its DAP-resistant
variant identified two non-synonymous and one synonymous mutations. The non-
synonymous mutations consisted of a S829L substitution in mprF and a T331I
substitution in vraS. The RT-qPCR experiments revealed an increased expression of
vraS, dltA, mprF, and sceD genes in DAP-resistant variant. Strikingly, the expression of
dltA and mprF genes was significantly downregulated by DAP.
Conclusion: The mprF and vraS genes were previously associated with DAP
resistance, however, none of the mutations described in this study had been previously
identified and linked to DAP resistance. Moreover, we provide a new insight into the
DAP action on S. aureus, in which the expression of key genes in DAP resistance is
decreased by the antibiotic.
Keywords: whole-genome sequencing, Staphylococcus aureus, daptomycin, SNP analysis, MprF
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INTRODUCTION
Daptomycin (DAP) is an alternative to vancomycin for invasive
methicillin-resistant Staphylococcus aureus (MRSA) infections or
for serious methicillin-susceptible S. aureus (MSSA) infections
in patients who are allergic to beta-lactams. The DAP non-
susceptibility in S. aureus (referred to as DAP resistance in this
study for the ease of presentation) is an increasing problem
and several reports have described the emergence of resistance
during DAP therapy (Lee et al., 2010; Mammina et al., 2010).
The current knowledge suggests that DAP resistance in S. aureus
is complex and results from mutational changes in a number
of different genes. Most clinical DAP-resistant S. aureus isolates
(MICs of >1 µg/ml) investigated to date, harbored mutations in
mprF, typically in the form of single-nucleotide polymorphisms
(SNPs) (Jones et al., 2008; Ernst et al., 2009; Mishra and
Bayer, 2013). The mprF gene encodes a bifunctional membrane
protein that catalyzes the synthesis and translocation (flipping)
of the positively charged phospholipid lysyl-phosphatidylglycerol
within its cell membrane. The amino acid substitutions in the
MprF protein identified in the strains showing resistance to DAP
lead to altered cell membrane phospholipid profiles. It results
in a cell membrane positive charge increase and changes in cell
membrane fluidity (Mishra et al., 2009). The dltABCD operon
is involved in the addition of D-alanine to teichoic acids in
many Gram-positive bacteria (Ernst et al., 2009). Mutations in
the dlt operon and/or altered expression of its genes lead to
a cell surface positive charge increase, as in the case of the
mprF mutations. Data from numerous studies have suggested
that charge repulsion arising from the mprF- and dlt-mediated
enhancement of positive surface charge is mainly responsible for
DAP-resistant phenotype among S. aureus strains (Jones et al.,
2008; Patel et al., 2011; Peleg et al., 2012; Gasch et al., 2013;
Yang et al., 2013; Cafiso et al., 2014; Kang et al., 2017; Ma et al.,
2018). It has recently been discovered that deletion of the clpX
gene caused a small reduction in DAP susceptibility (Bæk et al.,
2014). The highly conserved ClpX chaperone facilitates protein
folding and with the ClpP protease, forming the ClpXP protease,
controls cell size and is required for growth of S. aureus at low
temperature (Stahlhut et al., 2017). Other determinants involved
in DAP resistance include genes that encode enzymes associated
with phospholipid metabolism, such as phosphatidylglycerol and
cardiolipin synthetases (pgsA and cls, respectively) (Fischer et al.,
2011). There are also two-component regulatory systems like
WalKR also known as YycFG, VraSR or GraRS that directly or
indirectly modulate transcription of a number of genes encoding
proteins involved in wall metabolism and permeability (Tran
et al., 2015). The emergence of mutations in these regulatory
genes have been also associated with DAP resistance in S. aureus
(Friedman et al., 2006; Mehta et al., 2012).
The main purpose of this study was to apply whole
genome sequencing (WGS) to a clinical pair of MSSA isolates
(DAP-susceptible and DAP-resistant) to detect genome-wide
DNA sequence polymorphisms associated with DAP resistance.
Additionally, the gene expression profiles of determinants
previously linked with DAP resistance were investigated.
Furthermore, the net cell-surface charge as the main mechanism




The isolates were obtained from a 50-year-old male, with a history
of alcohol abuse and several comorbidities, who had a mitral
valve replacement and in the following 6 months experienced
two episodes of left-sided endocarditis, diagnosed according
to current guidelines (Habib et al., 2009). In the last episode,
Enterococcus faecalis and MSSA (isolate IT1-S) were obtained
from blood cultures. As the patient had previously shown an
allergic reaction to penicillins, treatment was instituted with
gentamycin (discontinued after 2 weeks) and DAP at the dose
of 500 mg daily. After 4 weeks the patient’s conditions remained
serious, with no improvement. Blood culture yield an MSSA
(isolate IT4-R) that was resistant to DAP (Table 1).
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility was tested by the broth
microdilution method using the customized microplates
ITGPOSF2 (Biomedical Service s.r.l., Scorzé, Venice, Italy)
according to the manufacturer’s instructions. The antibiotics
tested were ampicillin, ampicillin/sulbactam, cefoxitin,
ceftaroline, clindamycin, DAP, erythromycin, fusidic acid,
gentamicin, levofloxacin, mupirocin, oxacillin, rifampicin,
tigecycline, trimethoprim/sulfamethoxazole and vancomycin.
The breakpoints indicated by the EUCAST guidelines were
applied1.
Next-Generation Sequencing (NGS)
Next-generation sequencing (NGS) was carried out on the
Illumina MiSeq system using 300× 2 paired-end reads. Sequence
libraries were created using the standard Illumina Nextera
XT library creation kit. The SeqMan NGen software version
11.2.1 (DNASTAR) was used for de novo assembly of the
reads and the resulting contigs were ordered by Mauve Contig
Mover. The remaining gaps between contigs were closed by
PCR amplification and Sanger sequencing allowing for the
analysis of fully closed chromosomes and plasmids. Manual
sequence editing was conducted using the SeqBuilder software
(DNASTAR). The DNA sequences were aligned using the
MegAlign (DNASTAR) and BLASTn software.
spa Typing and MLST
The procedure was conducted as previously described (Aires-de-
Sousa et al., 2006). The spa types were assigned using Ridom
StaphType software version 1.4.6 (Ridom GmbH, Würzburg,
Germany). The MLST STs were assigned through the publicly
available MLST server2 on the basis of WGS data.
1http://www.eucast.org/
2www.cbs.dtu.dk/services/MLST
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TABLE 1 | Characteristics of the study isolates.
S. aureus isolate Isolation Source Infection MIC µg/ml (broth microdilution method) of selected antibiotics spa type MLST
Vancomycin Daptomycin Clindamycin
IT1-S 30-04-2013 Blood Endocarditis 1 0.5 0.5 t223 ST22
IT4-R 01-06-2013 Blood Endocarditis 1 2 0.25 t223 ST22
RNA Sample Collection and Gene
Expression Analysis Using Reverse
Transcription and Quantitative Real-Time
PCR (RT-qPCR)
Each isolate was grown in triplicate in Mueller Hinton Broth
(MHB) in the absence or presence of DAP. The overnight
cultures were diluted to produce an inoculum concentration
of approximately 108 cfu/ml. The inoculum was then diluted
1:100 in MHB supplemented with 50 µg/ml CaCl2 or in MHB
supplemented with 0.08 µg/ml DAP and 50 µg/ml CaCl2. It
resulted in starting number of the cells approximately 106 cfu/ml
in each culture. Cells were then harvested from the IT1-S and
IT4-R cultures grown to mid exponential (∼108 cfu/ml, after
5.5 h and 4 h, respectively), late exponential (∼109 cfu/ml, after
8 h and 6 h, respectively) and stationary (∼1010 cfu/ml, after
14 h and 12 h, respectively) phase. The cell concentration was
confirmed by colony counting after plating and incubation onto
blood agar plates. Total RNA was isolated using the RNeasy
Mini kit (Qiagen) according to the manufacturer’s instructions.
RNA was quantified using Qubit (Thermo Fisher Scientific) and
the quality of the RNA extracted was assessed by TapeStation
2200 (Agilent Technologies). The Agilent TapeStation 2200
system, which is an automated instrument for nucleic acid gel
electrophoresis, assigns RNA Integrity Number (RIN) values
ranging from 1 to 10, with 10 being the highest quality.
Only samples with preserved 16S and 23S peaks and RIN
values >8 were selected for gene expression analyses. The
RIN values >8 indicate intact, high quality RNA samples for
downstream applications (Fleige and Pfaﬄ, 2006). Total RNA was
further treated with Baseline-ZERO DNase (Epicentre) followed
by the RNeasy MinElute Cleanup kit (Qiagen) according to
the manufacturer’s instructions. The absence of contaminating
DNA was verified by PCR. For RT-qPCR analyses, an iTaq
Universal SYBR Green One-Step Kit (Bio-Rad Laboratories)
was used. Each reaction mix with a volume of 20 µl was
prepared with 300 nM each primer (final concentration) and
20 ng of template RNA. A CFX96 Touch Real-Time PCR
detection system (Bio-Rad Laboratories) was used for the
measurements using a protocol with the following thermal
cycling conditions: reverse transcription reaction at 50◦C for
10 min and polymerase activation and DNA denaturation at
95◦C for 1 min, followed by 35 cycles of denaturation at 95◦C
for 10 s and annealing/extension at 60◦C for 30 s. After the
last amplification cycle, a melting curve analysis was carried out
by heating from 65 to 95◦C in increments of 0.5◦C/s. Negative
controls (without template or reverse transcriptase enzyme)
were included in each run. Gene-specific primers (Table 2)
for the genes used in RT-qPCR experiments were designed
using SeqBuilder software (version 15.0.1) from DNASTAR.
Calculations of primer efficiencies were performed using the
software CFX Manager version 3.1 (Bio-Rad Laboratories).
Fold changes in the expression levels of the investigated genes
were normalized in relation to the levels of gyrB mRNA. The
relative changes in gene expression were quantified using the
Pfaﬄ method (Pfaﬄ, 2001): gene expression ratio = (Etarget)1Ct
target(control − sample)/(Ereference)1Ct reference(control − sample), where
Etarget is the amplification efficiency of target (gene of interest),
Ereference is the amplification efficiency of reference (gyrB), Ct is
the point at which the fluorescence rises above the background
fluorescence, 1Ct target is the Ct deviation of the control minus
the sample of the target gene transcript, and 1Ct reference is the
Ct deviation of the control minus the sample of the reference gene
transcript. The statistical significance of differences in the results
was analyzed with the Student t-test and P-values of ≤0.05 were
considered significant.
Relative Positive Surface Charge
Determination
The cells were grown overnight (16 h) in Tryptic Soy Broth
(TSB) medium in the absence of DAP, washed twice with 20 mM
morpholinepropanesulfonic acid (MOPS) buffer (pH 7.0), and
resuspended in the same buffer at an optical density at 600 nm
(OD600) of 1.0. The cells were incubated with cytochrome c
(Sigma) dissolved in 20 mM MOPS buffer (pH 7.0) using three
different concentrations: 50 µg/ml, 100 µg/ml, and 500 µg/ml.
Moreover, the cells incubated in 20 mM MOPS buffer (pH 7.0)
without cytochrome c were used as a negative control. After
15 min of incubation, the cells were pelleted by centrifugation
and absorbance of the supernatants was measured at 530 nm.
The amount of remaining (unbound) cytochrome c in the
supernatant was determined by comparison to a standard curve
(serially diluted cytochrome c). Cytochrome c is a cationic
peptide and there is a direct correlation between the amount
of unbound cytochrome c detected in the supernatant and the
positive charge of the bacterial surface (Peschel et al., 1999).
The data were converted and shown as the percent amount
of bound cytochrome c. Independent runs were performed in
triplicate on separate days. Changes in cytochrome c binding
were compared by the Student t-test. A P-value of ≤0.05 was
considered significant. Statistical analysis was performed using
the GraphPad software.
Membrane Potential Assay
DAP-induced bacterial membrane depolarization was performed
essentially as described previously (Silverman et al., 2003) by
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TABLE 2 | Primers used in the RT-qPCR study.
Gene description (designation) Gene position in the
chromosome
Primer sequence Primer position in the
gene
DNA gyrase subunit B (gyrB) 5034–6968 F: TGAAGCATTAGCTGGTTATG 5204–5223
R: ACGTTTTCTTCATCACGTTC 5679–5698
















844667–846124 F: GATGATAGGTGCCATTAAAG 844858– 844877
R: CAAATGTTAATCGGTGTTGC 845339–845358
Cell wall metabolism sensor histidine
kinase (walK)
25652–27478 F: GAGGTAACTATACGCAACG 26316–26334
R: GGTGTACGTAACTCATGTG 26802–26820
DNA-binding response regulator (graR) 663682–664356 F: TGGGATTTTAATGTTGCTGG 663748–663767
R: ATCACTAACAAATGCTTCATC 664228–664248





1227992–1228570 F: TTAGAGTAGTGTTAATACCAG 1228020–1228040
R: TATTCAATACCAGATAAGATAG 1228512–1228533
ATP-dependent Clp protease





using the membrane potential-sensitive fluorescent dye 3,3-
dipropylthiacarbocyanine [DiSC3(5); Thermo Fisher Scientific]
with the following modifications. Briefly, isolates were grown at
37◦C to early exponential phase (OD600, 0.2 to 0.3) in 50 ml
of MHB. Cells were harvested by centrifugation, washed twice
with 5 mM HEPES buffer (pH 7.2) supplemented with 50 µg/ml
CaCl2 and resuspended in the same buffer (containing 50 µg/ml
CaCl2) to an OD600 of 0.2. The dye DiSC3(5) was added to
cell suspension to make a final concentration of 0.18 µM. The
cells were incubated with the dye DiSC3(5) for 15 min at room
temperature. Then KCl was added (100 mM final concentration)
to equilibrate the cytoplasmic and external potassium ions
(K+) concentrations. The 200-µl cell suspension aliquots were
transferred to the wells of a white 96-well microplate. The desired
DAP concentrations were subsequently added to the microplate
wells and an increase in the fluorescence intensity at a wavelength
of 670 nm was measured over 60 min using a Synergy HTX
multimode microplate reader (BioTek). The fluorescence leakage
(FL) was determined using equation as previously described
by Cheng et al. (2014): FL = (FF − FB) − (FI − FB), where
FF was the fluorescence intensity of the cell suspension over
60 min of treatment with DAP, FI was the initial fluorescence
intensity of the cell suspension with DAP, and FB was the
fluorescence intensity of the blank (only cells and the dye).
Data were normalized relative to the maximum fluorescence
leakage (expressed as 100%). Results were shown as the mean of
triplicate measurements. Changes in membrane depolarization
were compared by the Student t-test. A P-value of ≤0.05 was




Chromosome and plasmid sequence data of the two S. aureus
isolates were annotated using the NCBI Prokaryotic Genome




The first aim of our investigations was to determine the
antibiotic susceptibility of the isolates recovered before and after
treatment with DAP. The MIC values for selected antibiotics
are presented in Table 1. Antibiotic susceptibility testing showed
that isolate IT1-S (recovered before the DAP treatment) was
susceptible to all the antibiotics tested with the exception of
3www.ncbi.nlm.nih.gov/nucleotide
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clindamycin that showed intermediate resistance (MIC = 0.5
µg/ml). MIC value for DAP was 0.5 µg/ml. Isolate IT4-R
(recovered after the DAP treatment) was resistant to DAP
(MIC = 2 µg/ml) and susceptible to all other antibiotics tested.
Therefore, the mechanism conferring DAP resistance in IT4-
R did not confer resistance to other antibiotics, including
vancomycin, for which the two isolates showed the same MIC
(Table 1).
Molecular Characterization
This part of the study aimed at molecular typing of the isolates
and comparing their virulence potential. The characteristics
of the isolates are shown in Table 1. spa typing assigned
spa type t223 to both isolates. From the WGS data, in silico
MLST identified the isolates belonged to single sequence type
(ST) 22. Moreover, the isolates were positive for toxic shock
syndrome toxin-1, enterotoxin N, enterotoxin O and enterotoxin
P. The full virulence profile of the IT1-S and IT4-R isolates
is presented in Table 3. Both isolates showed exactly the
same virulence potential as they carried the same set of the
genes.
The S. aureus IT4-R Genome Carries
Mutations That Can Be Linked to DAP
Resistance
Subsequently, the genome sequences of the two isolates were
compared to identify mutational changes responsible for the
DAP resistance of the IT4-R isolate. The analyzed S. aureus
isolates, IT1-S and IT4-R, had identical genomes in length, which
included a 2,774,523-bp circular chromosome (32.8% G+C
content) and a 34,104-bp circular plasmid (30.3% G+C content).
The NCBI annotation pipeline revealed 2,895 genes in total in
each genome. Whole-genome comparison of both isolates, DAP-
susceptible and its DAP-resistant variant, identified three single
nucleotide polymorphisms (SNPs), one in each of three genes.
Two of the mutations were non-synonymous (leading to a change
in the amino acid sequence in the translated gene product) while
the third mutation was synonymous (without change in amino
acid sequence). The non-synonymous mutations consisted of (i)
a S829L substitution in mprF and (ii) a T331I substitution in
vraS. The synonymous mutation was found in sceD (A→G at the
nucleotide 105), the gene involved in cell wall turnover, growth
and cell separation (Howden et al., 2010). Although mprF and
vraS genes were previously associated with DAP resistance, none
of the SNPs that we identified had been previously described and
linked to DAP resistance.
Comparison of Gene Expression
Between the IT1-S and IT-4 Isolates
We wanted to know if the mutations, which arose in genomic
DNA during DAP therapy had an influence on gene expression.
The gene expression levels of IT4-R were compared to that of its
parent strain IT1-S during mid-exponential, late exponential and
stationary growth phases using RT-qPCR (Figure 1). All three
genes, in which the SNPs were identified in this study (mprF, sceD
and vraS) and the genes previously linked with DAP resistance







spa 75928–77478 Immunoglobulin G binding protein A
sdrC 560282–563191 Ser-Asp rich fibrinogen-binding
protein C
sdrE 567737–571072 Ser-Asp rich fibrinogen-binding
protein E
vwb 806446–807954 von Willebrand factor-binding protein
eap 900239–900673 Extracellular adherence protein
atl 976444–980217 Bifunctional autolysin Atl
fib 1082735–1083064 Fibrinogen-binding protein
efb 1087580–1087957 Extracellular fibrinogen-binding protein
ebpS 1477847–1479277 Cell surface elastin binding protein
eap/map 1951015–1953063 Extracellular adherence protein
sdrH 2025520–2026779 Ser-Asp rich fibrinogen-binding
portein H
eap 2227772–2228197 Extracellular adherence protein
sbi 2437079–2438389 Immunoglobulin-binding protein
fnbA 2529493–2532540 Fibronectin-binding protein A
clfB 2677709–2680114 Clumping factor ClfB, fibrinogen
binding protein
cna 2750354–2753344 Collagen adhesin precursor
Toxins
hla 1090201–1091160 Alpha-hemolysin precursor
SEntP 1591838–1592542 Enterotoxin P
SEntG 1822884–1823660 Extracellular enterotoxin type G
precursor
SEntN 1823943–1824698 Enterotoxin N
SEntI 1825661–1826389 Extracellular enterotoxin type I
precursor
SEntO 1827424–1828188 Enterotoxin O
tsst 2010878–2011582 Toxic shock syndrome toxin-1
hld 2031459–2031593 Delta-hemolysin
hlgA 2438880–2439808 Gamma-hemolysin chain II precursor
hlgC 2440376–2441323 Gamma-hemolysin component C
hlgB 2441325–2442302 Gamma-hemolysin component B
precursor
Exoenzymes
coa 211498–212859 Staphylocoagulase precursor
geh 314970–317045 Glycerol ester hydrolase
nuc 810521–811207 Thermonuclease
sspB 970467–971648 Cysteine protease staphopain B
sspA 971730–972776 Serine V8 protease
nucI 1278542–1279075 Thermonuclease
scpA 1923362–1924528 Cysteine protease staphopain A
scn 1957164–1957377 Complement inhibitor SCIN
sak 1959588–1960079 Staphylokinase
hysA 2220411–2222837 Hyaluronate lyase
lip 2733778–2735820 Triacylglycerol lipase
(dltA, walK, graR, cls, pgsA and clpX) were investigated. The vraS
gene showed significantly increased expression (P value ≤ 0.05)
in IT4-R relative to IT1-S in all growth phases in both the absence
and presence of DAP (Figure 1 and Supplementary Table S1).
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Likewise, dltA, mprF and sceD were upregulated in IT4-R but the
differences between the two isolates were not always statistically
significant (Supplementary Table S1). Other genes showed no
difference in regulation between the two isolates. In conclusion,
the increased expression of the vraS, dltA, mprF, and sceD genes
was observed in the DAP-resistant variant compared to its parent
DAP-susceptible strain.
Influence of DAP on Gene Expression
It was shown previously that concentrations of some antibiotics
below the MIC were able to modulate the expression of virulence-
associated genes in S. aureus (Bernardo et al., 2004; Stevens
et al., 2007; Turner and Sriskandan, 2015). However, DAP seemed
to have no significant effects on virulence factor expression by
S. aureus (Otto et al., 2013). In the current study, we wanted to
explore if subinhibitory concentration of DAP could influence the
expression of the genes linked with DAP resistance. Therefore,
the expression levels of mprF, sceD, vraS, dltA, walK, graR, cls,
pgsA and clpX were compared in IT1-S or in IT4-R in the absence
and presence of DAP during different stages of growth (Figure 1).
DAP significantly downregulated the expression of the dltA gene.
With the exception of the stationary phase in IT4-R, the mprF
gene was also downregulated in the presence of DAP. However,
the difference was not significant for the mid-exponential phase
in IT1-S (Supplementary Table S2). Based on these observations
we could conclude that DAP downregulates the expression of
dltA and mprF genes.
The Effect of Growth Phase on Gene
Expression
Throughout bacterial growth, the cell density, nutrient
conditions, pH, and other factors are changing. Therefore,
we analyzed the growth phase-dependent gene expression
profiles (Figure 1). In both isolates in the absence or presence
of DAP, the sceD gene showed the highest transcript level
in the mid-exponential phase and during further growth its
transcriptional activity was decreasing, while the highest and
lowest transcriptional activity of cls was found in late exponential
and mid-exponential growth phases, respectively (Figure 1).
However, the differences between the growth phases were
not always statistically significant (Supplementary Table S3).
Moreover, dltA and graR were always the most active in the late
exponential growth phase and clpX in the mid-exponential phase.
In case of dltA and graR the differences were always statistically
significant. In conclusion, independently on mutational changes
during DAP therapy as well as presence or absence of DAP in
medium, strong impact of the growth phase on gene expression
was observed in case of sceD and cls.
Relative Positive Surface Charge
The emergence of DAP-resistant S. aureus strains can occur by
way of several different mechanisms involving the cell membrane
and/or cell wall. Recent analysis of a panel of clinical DAP-
resistant MSSA isolates showed that enhancement of positive
surface charge, reducing DAP binding, may be the main
FIGURE 1 | Expression analysis of genes previously linked with DAP resistance. Transcript levels of the analyzed genes were determined by RT-qPCR in relation to
gyrB expression. Values represent the mean of results obtained for three replicates independently grown cultures for each isolate. Error bars indicate the standard
deviation of comparisons between three replicates. IT1-S – isolate IT1-S grown in the absence of DAP, IT1-S-DAP – isolate IT1-S grown in the presence of
0.08 µg/ml daptomycin, IT4-R – isolate grown in the absence of daptomycin, IT4-R-DAP – isolate IT1-S grown in the presence of 0.08 µg/ml daptomycin. Mid-log,
mid-exponential growth phase; Late Exp, late exponential growth phase; Plateau, stationary growth phase.
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mechanism of DAP resistance among the MSSA strains (Kang
et al., 2017). To test this hypothesis the cytochrome c binding
analysis was performed. Cytochrome c binding assay revealed
that DAP-resistant isolate IT4-R had significantly decreased
positive surface charge compared to its DAP-susceptible parental
isolate IT1-S (Figure 2).
DAP-Induced Membrane Depolarization
The target of DAP is the bacterial cell membrane (Silverman
et al., 2003). Once inside the membrane, DAP aggregates
(Pogliano et al., 2012) leading to rapid depolarization and loss
of membrane potential, and thus to bacterial cell death. We
compared depolarization of the cell membrane of the IT1-S
and IT4-R isolates to identify differences, which could explain
higher resistance of the mutant to DAP. Changes in membrane
depolarization were determined by membrane potential assay
using a fluorescence dye, DiSC3(5). The fluorescence of DiSC3(5)
decreases as it incorporates into polarized membranes because at
high concentration the dye aggregates and self-quenches. With
the addition of a membrane-disrupting agent, such as DAP, the
dye is released from cells into the media, which in turn leads to
fluorescence dequenching. DAP concentrations that were used
in the membrane potential assay were 1 µg/ml and 4 µg/ml
that corresponded to twice the DAP MIC for IT1-S and IT4-
R, respectively. The addition of DAP into the assay medium
gradually depolarized the membrane of the isolates (Figure 3).
The rate of membrane depolarization was reduced in DAP-
resistant isolate compared to that of DAP-susceptible isolate.
However, statistically significant differences (p < 0.05) between
IT1-S and IT4-R at the same time points were observed only
between 10 and 40 min at the DAP concentration of 1 µg/ml, and
between 10 and 30 min at the DAP concentration of 4 µg/ml. At
the DAP concentration of 1 µg/ml, a maximum depolarization
(100%) of the IT1-S membrane was observed after 50 min,
while the antibiotic depolarized the membrane of IT4-R by
85.6% (compared to the maximum depolarization of IT1-S) after
FIGURE 2 | Binding analysis of cytochrome c to surface of S. aureus cells.
The graph shows percentage of cytochrome c bound after incubation of
S. aureus cells with different concentrations of cytochrome c. The data
represent the means from three technical replicates. Error bars indicate the
standard deviation of comparisons between three technical replicates.
A P-value of ≤0.05 was considered significant.
60 min. At the DAP concentration of 4 µg/ml, the time to reach
the maximum of depolarization was shorter for IT1-S (30 min),
than for IT4-R (40 min). However, the peak of depolarization
for IT4-R was lower than that of IT1-S (91.2% versus 100%).
This assay demonstrated that both the total amount of membrane
depolarization and the rate of depolarization were reduced in
DAP-resistant isolate, which can explain higher resistance of the
mutant to the antibiotic.
DISCUSSION
The MprF protein consists of an N-terminal transmembrane
flippase domain, C-terminal catalytic synthase domain, and a
central bifunctional domain bridging the flippase and synthase
domains. The changes in amino acid sequence linked to DAP
resistance of S. aureus were identified in all domains of MprF:
G61V in the flippase domain (Peleg et al., 2012); S295L, P314L,
S337L, T345A, and T345I in a central bifunctional domain
(Friedman et al., 2006; Mehta et al., 2012; Peleg et al., 2012);
and I420N and L826F in synthase domain (Peleg et al., 2012).
Taking into account a frequency of above mutations they occur
most often in a central bifunctional domain both in clinical and
in vitro obtained isolates. Our study revealed a novel amino acid
substitution in C-terminal catalytic synthase domain of the MprF
protein at amino acid residue 829 (S829L), which was found in a
clinical isolate with the DAP-resistant phenotype after prolonged
treatment of a patient with endocarditis initially infected with a
fully susceptible strain.
Although several molecular mechanisms of resistance to DAP
have been proposed, mainly associated with phenotypic changes
in cell wall and cell membrane, the basis of DAP resistance in
S. aureus is still incompletely understood (Tran et al., 2015). This
results from the fact that DAP resistance in S. aureus appears to
be multi-factorial and strain specific. It has been proposed that
charge repulsion of the DAP antibiotic molecule from the cell
surface, which is associated with the increased positive charge
of cell membrane and cell wall may be the main mechanism to
explain DAP resistance in S. aureus strains (Jones et al., 2008;
Patel et al., 2011; Peleg et al., 2012; Gasch et al., 2013; Yang
et al., 2013; Cafiso et al., 2014; Kang et al., 2017; Ma et al., 2018).
During the emergence of DAP resistance in S. aureus, the first
SNPs in the genomic DNA appear most often in the mprF gene
and are associated with a gain of enzymatic function, resulting in
an increase in the positive charge of the cell membrane (Bayer
et al., 2014). The mutant in this study displayed an amino acid
substitution in the MprF protein and increased expression of
the mprF gene. These two factors possibly reduced dissipation
of membrane potential of the mutant in the presence of DAP,
promoting resistance to the antibiotic molecules by electrostatic
repulsion.
Another strategy utilized by S. aureus to enhance the positive
surface charge is increased expression of the dlt operon (Bertsche
et al., 2013; Cafiso et al., 2014; Mishra et al., 2014). The dltABCD
gene products are involved in the incorporation of D-alanine into
cell wall teichoic acids. Although in the RT-qPCR experiments
we observed increased expression of the dltA gene in IT4-R, this
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FIGURE 3 | DAP-induced membrane depolarization. The graph shows percentage of membrane depolarization after 10, 20, 30, 40, 50, and 60 min of the antibiotic
treatment. DAP concentrations in brackets. The data represent the means from three technical replicates. Error bars indicate the standard deviation of comparisons
between three technical replicates.
isolate had higher capacity to bind cytochrome c than IT1-S.
However, the test with cytochrome c measures the overall cell
surface charge and not the membrane charge itself. Moreover, it
has been previously shown that some DAP-resistant isolates with
mprF mutations did not show significantly altered net surface
charge (Bayer et al., 2015). It will be interesting to compare
more clinical DAP-resistant S. aureus strains with non-increased
surface charge relative to their respective isogenic susceptible
strains by DAP-induced cell membrane potential assay to explore
further the mechanisms of DAP resistance in S. aureus.
Second non-synonymous mutation identified in the genome
of IT4-R was found in vraS, a gene of the two-component system
VraSR, which positively modulates the regulation of cell-wall
biosynthesis pathway in S. aureus. Moreover, the expression levels
of vraS were significantly increased in IT4-R compared to that
of DAP-susceptible counterpart. In a study recently published
by Chen et al. (2018), the authors showed results indicating a
causal relationship between the L431F substitution in the MprF
protein and increased expression of the vraSR genes in the DAP-
resistant strain leading concurrently to vancomycin resistance.
But how the mutant MprF protein affected expression of vraSR
and the cell wall-related genes was not elucidated. We can assume
that in the IT4-R isolate the amino acid substitution in the
MprF synthase domain (S829L) can lead not only to changes in
the cell membrane of but also to pleiotropic effects, including
upregulation of the VraSR system and the transglycosylase
gene sceD, a feature involved in cell-wall turnover, resulting in
increased resistance to DAP.
A previous study showed that the mprF sequence variations
within the same clonal complex were not only associated with
the DAP-resistant S. aureus strains but also with DAP-susceptible
strains (Bayer et al., 2014). There is an increasing interest to
use WGS for genotypic prediction of antimicrobial resistance,
which has the potential to reduce bed-to-diagnosis time by
eliminating culture-based antimicrobial susceptibility testing.
However, accuracy of predictions depends on a priori knowledge
of mutations in mprF as well as in other genes that are conferring
the DAP-resistant phenotype in S. aureus. Our study identified
two novel SNPs leading to the amino acid substitutions (S829L in
MprF and T331I in VraS), which can be linked to S. aureus DAP
resistance, improving our recognition of resistance signatures
within core genomic determinants.
This study provided a new insight into the DAP action on
S. aureus by way of decreasing the expression of mprF and dltA.
The dltABCD operon, like the mprF gene, contributes to the
staphylococcal net positive surface charge. It will be important
to identify the mechanism by which DAP reduces transcriptional
activity of the genes, which contribute to positive surface charge
since our study showed that the antibiotic did not influence
the expression of two-component systems, VraSR, GraSR, and
WalKR, associated with resistance of S. aureus to DAP.
CONCLUSION
We identified the new point mutation in the mprF gene leading to
the amino acid substitution in the MprF protein that counteracts
DAP antibiotic activity. Our results support the suggestion that
vraSR contributes directly or indirectly to DAP resistance in
S. aureus. Description of new mutations in the core genome,
which can be linked with S. aureus resistance to DAP will
allow development of better and more rapid diagnostic methods
for identifying of drug resistance. The membrane potential
assay demonstrated that both the total amount of membrane
depolarization and the rate of depolarization were reduced in
DAP-resistant isolate, possibly resulting in resistance to the
antibiotic molecules by electrostatic repulsion. However, the
reduced effect of DAP on membrane depolarization in DAP-
resistant isolate, compared to its DAP-susceptible parent, was
not associated with increased positive net cell surface charge,
which warrants further investigation of a higher number of such
isolates to better understand the mechanisms of DAP resistance
in S. aureus. Finally, we shed a new light on the DAP action in
S. aureus, in which the expression of key genes in DAP resistance
is decreased by the antibiotic.
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